Independent & educational platform Not a government body. No link or affiliation with any government organisation. Made for learning only. Test only systems you own or are authorised to test. Become a Partner or Sponsor → Full disclaimer

CVE-2026-105667

high

In the default configuration, the HL7 listener accepts ADT^A40 patient-merge messages without authenticating the sending application.

In the default configuration, the HL7 listener accepts ADT^A40 patient-merge messages without authenticating the sending application. A remote sender can reassign studies and related workflow records from one patient identity to another. The archive's unmerge does not reverse this.

CVSS
7.5
7.5 (CVSS v3.1)
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:N
Severity source: NVD CVSS v3.1 (ics-cert@hq.dhs.gov)
Timeline (UTC)
Published: 2026-10-16 15:17
Modified: 2026-10-16 20:04
NVD status: Deferred
Last synced 1 day ago
Verified against the source API 2026-10-27 07:03 UTC
Exploitation
Not listed in CISA KEV (as of last catalog sync)
Absence from KEV does not mean a CVE is not exploited. Exploitation status: unknown (no authoritative evidence in our sources).

Affected products

Not reported by the source (unknown — not "none").

Weakness classification (CWE)

Source: NVD / CISA. “NVD-CWE-Other” and “NVD-CWE-noinfo” mean NVD could not assign a specific weakness.

Mitigation & advisories

No vendor advisory or patch reference tagged by NVD. Check the references below.

References

Data sources

NVD CVE API 2.0 — fetched 2026-10-27 07:03 UTC · record ↗

Learn the basics

Understanding CVEs and CVSS Scores